Internal Medicine · Bronx, NY
NPI
1528312394
Since 2012
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
253 E 142nd St
Bronx, NY, 10451
Phone (646) 979-9050
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,355
78 services
Medicare patients, 2024
24
Average age 70
Drug cost, 2024
$1.9M
12,895 prescriptions
Company payments, 2025
$6,177
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zerremi D Caga-Anan was code 99214 (office e&m - established), 30 times for 12 patients. In total Zerremi D Caga-Anan billed 78 services in 17 codes, and Medicare paid $7,355.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 30 | 12 | $108.46 | $3,254 |
| 99213 Office E&M - Established | Office | 21 | 12 | $65.77 | $1,381 |
By year: 2023 $7,391 for 81 services; 2024 $7,355 for 78 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zerremi D Caga-Anan prescribed most often to Medicare patients was Atorvastatin Calcium, with 654 prescriptions and refills. In total Zerremi D Caga-Anan wrote 12,895 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 654 | 1,134 | 172 | $4,561 |
| Diclofenac Sodium Er Diclofenac Sodium | 528 | 528 | 47 | $42K |
| Gabapentin Generic | 524 | 582 | 109 | $3,276 |
| Metformin Hcl Generic | 470 | 655 | 106 | $2,175 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 357 | 422 | 89 | $13K |
| Ezetimibe Generic | 350 | 476 | 69 | $5,012 |
| Fluocinonide Generic | 333 | 333 | 23 | $32K |
| Losartan Potassium Generic | 327 | 559 | 78 | $2,210 |
| Farxiga Dapagliflozin Propanediol | 308 | 371 | 59 | $200K |
| Amlodipine Besylate Generic | 304 | 638 | 92 | $1,547 |
| Doxepin Hcl Generic | 303 | 303 | 25 | $34K |
| Meloxicam Generic | 250 | 258 | 69 | $714 |
| Montelukast Sodium Generic | 233 | 311 | 72 | $1,163 |
| Levothyroxine Sodium Generic | 226 | 300 | 44 | $1,873 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 221 | 241 | 48 | $149K |
Brand drugs: 2,503 claims; generic drugs: 10,153 claims; opioid claims: 275.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zerremi D Caga-Anan $6,177 ($6,177 in general payments such as food, travel and fees) from 23 companies. The largest payer was Intra-Sana Laboratories with $1,484.
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 24 | $1,484 |
| Ardelyx, Inc. ARDX | 21 | $656 |
| Novo Nordisk Inc NVO | 13 | $557 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $532 |
| Xeris Pharmaceuticals, Inc. | 5 | $439 |
| Dexcom, Inc. DXCM | 6 | $388 |
| Abbvie Inc. ABBV | 16 | $315 |
| GlaxoSmithKline, LLC. GSK | 12 | $247 |
| Exact Sciences Corporation EXAS | 7 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $230 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.